期刊文献+

胸腺瘤WHO组织学分型与胸腺瘤诊治的关系 被引量:9

WHO Histologic Classification of Thymoma and its Relationship with Thymoma Diagnosis and Treatment
原文传递
导出
摘要 目的探讨胸腺瘤WHO组织学分型(WHO histologic classification of thymoma)在胸腺瘤诊治中的临床意义。方法采用胸腺瘤WHO组织学分型对79例胸腺瘤病例进行病理分类,比较不同病理类型与伴发重症肌无力(Myasthe-niagravis,MG)、Masaoka分期及临床预后的关系。结果在各型胸腺瘤中,A、AB、B1、B2、B3和C型伴发MG分别为37.5%(3/8)、53.8%(7/13)、70%(14/20)、88.5%(23/26)、33.3%(3/9)、0%(0/3)。B型胸腺瘤伴发MG为72.7%(40/55),明显高于A型和AB型胸腺瘤的47.6%(10/21,P<0.05)。B2胸腺瘤伴发MG明显高于B1、B3型(P<0.01)。在各型胸腺瘤中,A、AB、B1、B2、B3、C型胸腺瘤发生浸润或转移者分别为12.5%(1/8)、23.1%(3/13)、75%(15/20)、84.6%(22/26)、100%(9/9)、100%(3/3)。B型胸腺瘤浸润性明显高于A型、AB型胸腺瘤(P<0.01)。在各型胸腺瘤中,以C型胸腺瘤浸润性最强。在所有胸腺瘤中,5年总生存率为72.4%。A型、AB型5年生存率为93.5%,B型胸腺瘤为71.8%,其中B1型、B2型、B3型分别为81.6%、70.4%和56.4%。A型、AB型胸腺瘤5年生存期明显长于B型(P<0.05)。COX回归模型多因素分析发现胸腺瘤WHO组织学分型、Masaoka分期、手术切除方式是影响胸腺瘤预后的独立危险因素。结论胸腺瘤WHO组织学分型与伴发MG相关,反映肿瘤上皮细胞的浸润功能,可以评价患者预后。 Objective To explore the clinical significance of WHO histologic classification of thymoma in diagnosing and treating thymomas.Methods To review the pathological sections of 79 patients with thymoma from 1996-2008 using WHO classification(1999),the statistical software was used to analyze the relationship among the WHO classification,MG,clinical stages and prognosis.Results MG were associated with 37.5%(3/8),53.8%(7/13),70.0%(14/20),88.5%(23/26),33.3%(3/9),0%(0/3) patients in type A,AB,B1,B2,B3 and C thymomas,respectively.Type B associated with MG was 72.7%(40/55),which was higher than 47.6%(10/21)of type A and type B(P0.05).Type B2 associated with MG was higher than type B1,B3(P0.01).The invasiveness of tumors was 12.5%(1/8),23.1%(3/13),75.0%(15/20),84.6%(22/26),100.0%(9/9),100.0%(3/3) for type A,AB,B1,B2,B3 and C thymomas respectively.Type B thymomas were more invasive than type A and AB(P0.01).Type C were the most invasive in all the thymomas.Total 5-year survival rate in all the thymomas was 72.4%.5-year survival rate was 93.5%,71.8% in type A,type AB and type B,respectively.5-year survival rate was 81.6%、70.4% and 56.4% in type B1,B2,B3,respectively.5-year survival in type A and type AB was longer than type B(P0.05).By multivariate analysis,WHO histologic classification,Masaoka staging system and complete resection were significant independent prognostic factors.Conclusion WHO histologic classification of thymoma was associated with MG,reflected the invasive function of thymic epithelial tumors,may evaluate the prognosis of patients with thymoma.
出处 《中华全科医学》 2009年第12期1304-1306,共3页 Chinese Journal of General Practice
关键词 胸腺瘤 WHO组织学分型 多因素分析 Thymoma WHO histologic classification Multivariate analysis
  • 相关文献

参考文献10

  • 1王新允,陈云新,王爱香,张淑敏.Histologic Classification of Thymoma and Its Relationship with Myasthenia Gravis and Clinical Stages of the Tumor[J].The Chinese-German Journal of Clinical Oncology,2005,4(5):314-316. 被引量:1
  • 2吴涛,涂来慧,王志农,张仁琴,蒋建明,丁素菊,金海.胸腺瘤WHO分类与重症肌无力临床诊治的关系[J].第二军医大学学报,2003,24(11):1167-1169. 被引量:4
  • 3田欣伦,朱元珏.胸腺瘤的诊断和预后影响因素分析[J].中华内科杂志,2004,43(9):657-660. 被引量:3
  • 4Kirchner T, Tzartos S, Hoppe F, et al. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors[ J]. Am J Pathol, 1998,152: 437-444.
  • 5Wilisch A, Gutsche S, Hoffacker V, et al. Association of AchR α subunit gene expression in mixed thymoma with myasthenia gravis [J]. Neurology, 1999,52 : 1460-1466.
  • 6Muller-Hermelink HK, Marx A. Pathological aspects of malignant and benign thymic disorders [ J ]. Ann Med, 1999,31, Suppl 2 : 5-14.
  • 7Okumura M, Miyoshi S, Fujii Y, et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms : a study of 146 consecutive tumors[ J ]. Am J Surg Pathol,2001,25 (1) : 103-110.
  • 8Rena O, Papalia E, Maggi G, et al. World Health Organization classification: an independent prognosis factor in resected thymomas [ J ]. Lung Cancer,2005,50( 1 ) :59-66.
  • 9Okumura M, Ohto M, Tateyama H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of htymoma : a clinical study of 273 patients [ J ]. Cancer, 2002,94 ( 3 ) : 624-632.
  • 10Azad NS, Ahmad Z, Ahsan A, et al. Thymoma: a clinicopathologic association of World Health Organization histologic subtype and invasire behaviour[ J ]. J Coil Physicians Surg Pak, 2007,17 ( 11 ) :658- 661.

二级参考文献28

  • 1PAN Tiecheng, YAN Hua, ZHANG Ni, PAN Youming, TANG Yingxiong, WEN Xiang, SONG Dingwei, HU Ming, LIU Ligang, LIU Zixiong, YANG Mingshan, XU Jinzhi, PU Bitao, GAO Boting Department of Thoracis Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.Study on the Clinical Effectiveness of Thymectomy for Myasthenia Gravis[J].The Chinese-German Journal of Clinical Oncology,2002,1(1):36-37. 被引量:1
  • 2Lardinosis D, Rechsteiner R, Lang H, et al. Prognostic relevance of Masaoka and Mtiller-Hermelink classification in patients with thymic tumors[J]. Ann Thorac Surg,2000,69(5):1550-1555.
  • 3Okumura M, Miyoshi S, Fuji Y,et al. Clinical and functional significance of WHO classification on human thymic epithelial neoplasms[J ]. Am J S urg Pathol, 2001,25 ( 1 ) : 103-110.
  • 4Hoffacker V,Schuhz A,Tiesinga JJ,et al. Thymoma alter the T-cell subset composition in the blood:a potential mechanism for thymoma-associated autoimmune disease [J]. Blood, 2000,96(12) :3872-3879.
  • 5Kirchner T, Tzartos S, Hoppe F,et al. Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors[J].Am d Pathol,1988,130(2):268-280.
  • 6Schultz A, Hoffacker V, Wilisch A, et al. Neurofilament is an autoantigenic determinant in myasthenla gravis[J]. Ann Neurol,1999,46(2):167-175.
  • 7Wilsch A,Gutsche S,Hoffacker V,et al. Association of AChR a subunit gene expression in mixed thymoma with myasthenia gravis [J]. Neurology,1999,52(7):1460-1466.
  • 8Sommer N, Willox N, Harcourt GC, et al. Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells[J]. Ann neurol, 1990,28 (3) : 312-319.
  • 9Rosai J, Levine GD. Tumours of the thymus [B]. Washington DC : Army Forces Institute of Pathology, 1976.1-100.
  • 10Marine M,MUller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epthelial cells to the cortical and medullary differentiation of thymus [J]. Virchows Arch A Pathol Anat Histopath, 1985,407 (2) : 119-149.

共引文献5

同被引文献50

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部